Bausch Health Companies BHC
NYSE BHC
$6.44 -0.37 (-5.43%)
At close: Aug 21, 2026 · 4:00 PM EDT

Bausch Health Companies (BHC) Other Non-Current Assets (2009 - 2026)

Bausch Health Companies (BHC) posted Other Non-Current Assets of $358.0 million for Q2 2026, down 2.98% sequentially from $369.0 million in Q1 2026, and down 7.73% YoY from $388.0 million in Q2 2025.

Bausch Health Companies (BHC) Other Non-Current Assets (2009 - 2026) Analysis & Trends

Bausch Health Companies has reported Other Non-Current Assets for 18 years, with the latest figure at $358.0 million in Q2 2026.

  • Quarterly Other Non-Current Assets fell 7.73% year-over-year to $358.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $358.0 million (down 7.73% YoY) and the FY2025 annual result came in at $378.0 million, up 4.13% from the prior year.
  • Other Non-Current Assets fell to $358.0 million in Q2 2026 per BHC's latest filing, from $369.0 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $389.0 million in Q3 2024 and troughed at $307.0 million in Q4 2023.
  • A 5-year average of $348.1 million and a median of $339.5 million in 2022 frame the typical range for Other Non-Current Assets.
  • The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets tumbled 45.87% in 2022, then grew 21.79% in 2025.
  • Over 5 years, Other Non-Current Assets stood at $326.0 million in 2022, then decreased by 5.83% to $307.0 million in 2023, then increased by 18.24% to $363.0 million in 2024, then rose by 4.13% to $378.0 million in 2025, then slipped by 5.29% to $358.0 million in 2026.
  • According to Business Quant data, Other Non-Current Assets over the past three periods registered $358.0 million, $369.0 million, and $378.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - 56.35 Mn
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn 1.79 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn 384.00 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 503.80 Mn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 239.50 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn 1.06 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn 59.30 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn 304.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - 13.00 Mn
10 Bausch Health Companies 2.42 Bn 586.38 Mn 2.10 Bn 358.00 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 358.00 Mn
Mar 31, 2026 369.00 Mn
Dec 31, 2025 378.00 Mn
Sep 30, 2025 382.00 Mn
Jun 30, 2025 388.00 Mn
Mar 31, 2025 380.00 Mn
Dec 31, 2024 363.00 Mn
Sep 30, 2024 389.00 Mn
Jun 30, 2024 329.00 Mn
Mar 31, 2024 312.00 Mn
Dec 31, 2023 307.00 Mn
Sep 30, 2023 328.00 Mn
Jun 30, 2023 325.00 Mn
Mar 31, 2023 318.00 Mn
Dec 31, 2022 326.00 Mn
Sep 30, 2022 341.00 Mn
Jun 30, 2022 338.00 Mn
Mar 31, 2022 334.00 Mn
Dec 31, 2021 340.00 Mn
Sep 30, 2021 343.00 Mn